Owing to its functions in cardiac growth and development [17], we investigated Abl1’s role in doxorubicin-induced cardiomyopathy, and through gene reporter assays established Abl1’s cofactor activity on p53 target genes. The gene discussed is TP53; the disease is cardiomyopathy.